Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
[forminator_form id="25163"]

The deaths of two children in separate gene-editing clinical trials in China have come to light in rapid succession, intensifying scrutiny over the country's regulatory framework for cutting-edge medical research and the transparency of investigator-led studies.

A Chinese university has launched an investigation into the death of a six-year-old girl following an experimental gene-editing treatment, a fatality that was never publicly disclosed in the researchers' published work.

A 6-year-old girl died after receiving the world's first brain gene-editing treatment in China, and her death was never publicly reported, according to an investigation published on Wednesday by Science and Retraction Watch.